类风湿关节炎患者严重感染的发生率、危险因素及RABBIT评分验证
希腊多中心前瞻性队列纳入1557例类风湿关节炎患者,随访期间严重感染发生率为2.3/100患者年;既往严重感染史、糖尿病、慢性肺病及每日泼尼松≥10 mg为独立危险因素;RABBIT评分在1359例中预测的严重感染发生率与实际观察无差异。
要点
- 严重感染发生率为2.3/100患者年,既往严重感染史风险最高(IRR 4.15)。
- 每日泼尼松≥10 mg、慢性肺病、糖尿病亦为独立危险因素。
- RABBIT评分预测严重感染发生率与实际观察无显著差异。
核心结论
- 在该真实世界前瞻性RA队列中,严重感染发生率为2.3/100患者年,RABBIT评分能准确预测严重感染。
研究设计与样本
- 希腊多中心、前瞻性RA队列研究,纳入1557例患者,首次评估及一年后记录 demographics、疾病特征、治疗和合并症。
主要发现
- 随访期间记录38例严重感染,发生率比(IRR)为2.3/100患者年。
- 发生严重感染的患者病程更长、首次评估时HAQ更高,且更常有既往严重感染史、慢性肺病、心血管疾病和慢性肾脏病。
- 多因素分析显示,病程更长(IRR:1.05;95%CI:1.005,1.1)、既往严重感染史(IRR:4.15;95%CI:1.7,10.1)、糖尿病(IRR:2.55;95%CI:1.06,6.14)、慢性肺病(IRR:3.14;95%CI:1.35,7.27)及每日泼尼松剂量≥10 mg(IRR:4.77;95%CI:1.47,15.5)为严重感染的独立危险因素。
- 在1359例患者中使用RABBIT风险评分,预期严重感染发生率为1.71/100患者年,与观察到的1.91/100患者年无差异(P=0.97)。
关键数值与推荐
- 严重感染独立危险因素:病程(IRR 1.05;95%CI 1.005,1.1)、既往严重感染史(IRR 4.15;95%CI 1.7,10.1)、糖尿病(IRR 2.55;95%CI 1.06,6.14)、慢性肺病(IRR 3.14;95%CI 1.35,7.27)、每日泼尼松≥10 mg(IRR 4.77;95%CI 1.47,15.5)。
- RABBIT评分预测的严重感染发生率1.71/100患者年 vs 观察1.91/100患者年(P=0.97)。
临床怎么用
- 对RA患者应评估既往严重感染史、合并症及糖皮质激素剂量,以识别严重感染高危人群并采取预防措施。
- RABBIT评分可用于真实临床环境中预测RA患者的严重感染风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Predicting serious infections (SI) in patients with rheumatoid arthritis (RA) is crucial for the implementation of appropriate preventive measures. Here we aimed to identify risk factors for SI and to validate the RA Observation of Biologic Therapy (RABBIT) risk score in real-life settings. METHODS: A multi-centre, prospective, RA cohort study in Greece. Demographics, disease characteristics, treatments and comorbidities were documented at first evaluation and one year later. The incidence of SI was recorded and compared with the expected SI rate using the RABBIT risk score. RESULTS: A total of 1557 RA patients were included. During follow-up, 38 SI were recorded [incidence rate ratio (IRR): 2.3/100 patient-years]. Patients who developed SI had longer disease duration, higher HAQ at first evaluation and were more likely to have a history of previous SI, chronic lung disease, cardiovascular disease and chronic kidney disease. By multivariate analysis, longer disease duration (IRR: 1.05; 95% CI: 1.005, 1.1), history of previous SI (IRR: 4.15; 95% CI: 1.7, 10.1), diabetes (IRR: 2.55; 95% CI: 1.06, 6.14), chronic lung disease (IRR: 3.14; 95% CI: 1.35, 7.27) and daily prednisolone dose ≥10 mg (IRR: 4.77; 95% CI: 1.47, 15.5) were independent risk factors for SI. Using the RABBIT risk score in 1359 patients, the expected SI incidence rate was 1.71/100 patient-years, not different from the observed (1.91/100 patient-years; P = 0.97). CONCLUSION: In this large real-life, prospective study of RA patients, the incidence of SI was 2.3/100 patient-years. Longer disease duration, history of previous SI, comorbidities and high glucocorticoid dose were independently associated with SI. The RABBIT score accurately predicted SI in our cohort.
引用
- Thomas K, Lazarini A, Kaltsonoudis E, et al. Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis. Rheumatology (Oxford). 2021. PMID: 33295627. doi:10.1093/rheumatology/keaa557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。